Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabotropic glutamate receptors (mGluRs) are a family of G-protein-coupled receptors that respond to the neurotransmitter glutamate. They function primarily via modulation—not direct mediation—of synaptic transmission. mGluRs exist as obligate dimers with large extracellular ligand-binding domains and are divided into three groups based on structure/function. Their broad expression pattern makes them attractive therapeutic targets for various CNS disorders due to their role in neuromodulation across multiple brain regions.
Modulation of glutamate-mediated neurotransmission via G protein-coupled signaling pathways, affecting downstream second messengers and neuronal excitability. Can either enhance or inhibit neuronal activity depending on the mGluR subtype and its signaling cascade.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabotropic Glutamate Receptor (mGluR).